Evidence map›Paper›PMID 27424784›Full record

ArticleCell stem cell2016

Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors.

Edyta E Wojtowicz, Eric R Lechman, Karin G Hermans, Erwin M Schoof, Erno Wienholds, Ruth Isserlin, Peter A van Veelen, Mathilde J C Broekhuis, George M C Janssen, Aaron Trotman-Grant and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Proteogenomics of Prostate Cancer Radioresistance.Cancer research communications · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Taking One Step Back in Familial Hypercholesterolemia:Arteriosclerosis, thrombosis, and vascular biology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 2 countries.

Edyta E WojtowiczLaboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
Eric R LechmanPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Karin G HermansPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Erwin M SchoofPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Erno WienholdsPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Ruth IsserlinThe Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada.
Peter A van VeelenDepartments of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Mathilde J C BroekhuisLaboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
George M C JanssenDepartments of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Aaron Trotman-GrantPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Stephanie M DobsonPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Gabriela KrivdovaPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Jantje ElzingaPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
James KennedyPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Olga I GanPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
Ankit SinhaDepartment of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
Vladimir IgnatchenkoDepartment of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
Thomas KislingerDepartment of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
Bertien Dethmers-AusemaLaboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
Ellen WeersingLaboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
Mir Farshid AlemdehyDepartment of Hematology, Erasmus University Medical Center Cancer Institute, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands.
Hans W J de LooperDepartment of Hematology, Erasmus University Medical Center Cancer Institute, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands.
Gary D BaderThe Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada.
Martha RitsemaLaboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
Stefan J ErkelandDepartment of Immunology, Erasmus University Medical Center, Wytemaweg 80, 3015CN Rotterdam, the Netherlands.
Leonid V BystrykhLaboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
John E DickPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada. Electronic address: jdick@uhnres.utoronto.ca.
Gerald de HaanLaboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands. Electronic address: g.de.haan@umcg.nl.
University of Groningen · NLUniversity of Toronto · CAPrincess Margaret Cancer Centre · CAUniversity Health Network · CAErasmus MC Cancer Institute · NLLeiden University Medical Center · NLErasmus MC · NL

Funding

TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
Cytoscape: A Modeling Platform for Biomolecular NetworksR01GM070743 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2004 to 2016
$5.7M
Pathway Commons: Research Resource for Biological PathwaysP41HG004118 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI SANDER, CHRIS · 2008 to 2011
$3.8M
Cytoscape: A Modeling Platform for Biomolecular NetworksR01HG009979 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2017 to 2021
$3.5M
CIHRNHGRI NIH HHS P41 HG004118NHGRI NIH HHS R01 HG009979NIGMS NIH HHS P41 GM103504NIGMS NIH HHS R01 GM070743
6 · The paper itself

Abstract

Umbilical cord blood (CB) is a convenient and broadly used source of hematopoietic stem cells (HSCs) for allogeneic stem cell transplantation. However, limiting numbers of HSCs remain a major constraint for its clinical application. Although one feasible option would be to expand HSCs to improve therapeutic outcome, available protocols and the molecular mechanisms governing the self-renewal of HSCs are unclear. Here, we show that ectopic expression of a single microRNA (miRNA), miR-125a, in purified murine and human multipotent progenitors (MPPs) resulted in increased self-renewal and robust long-term multi-lineage repopulation in transplanted recipient mice. Using quantitative proteomics and western blot analysis, we identified a restricted set of miR-125a targets involved in conferring long-term repopulating capacity to MPPs in humans and mice. Our findings offer the innovative potential to use MPPs with enhanced self-renewal activity to augment limited sources of HSCs to improve clinical protocols.

Indexed as

Gene Expression RegulationADP-ribosyl Cyclase 1AnimalsAntigens, CD34Cell ProliferationCell Self RenewalGene Regulatory NetworksHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansIsotope LabelingMaleMice, Inbred C57BLMicroRNAsModels, BiologicalMultipotent Stem CellsADP-ribosyl Cyclase 1Antigens, CD34MicroRNAsMIRN125 microRNA, humanMirn125 microRNA, mouse

Identifiers

PMID27424784
PMCPMC5500905
OpenAlexW2462067774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.